Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
Mycoplasma hyopneumoniae inactivated , strain nl1042
Elanco GmbH
QI09AB13
Mycoplasma hyopneumoniae inactivated , strain nl1042
.
Emulsion for injection
POM: Prescription Only Medicine as defined in relevant national legislation
mycoplasma
Authorised
2010-11-26
Health Products Regulatory Authority 20 July 2018 CRN000YKD Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Stellamune Once. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per 2 ml dose: Active substance: Inactivated _Mycoplasma hyopneumoniae, _strain NL1042, between 4.5 and 5.2 log10 units*. *ELISA Relative Potency Units by comparison with a reference vaccine. Adjuvant: Amphigen Base 0.025 ml Drakeol 5 (Mineral oil) 0.075 ml. Excipients: Thiomersal 0.185 mg For a full list of exipients, see section 6.1 3 PHARMACEUTICAL FORM Emulsion for injection. Off white, translucent, semi turbid oil in water emulsion. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Fattening pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of piglets from 3 days of age to reduce lung lesions related to infection by _Mycoplasma hyopneumoniae _in fattening animals. Onset of immunity: 18 days following vaccination. Duration of immunity: 26 weeks following vaccination. For active immunisation of piglets from 3 weeks of age to reduce coughing and losses in weight gain related to infection by _Mycoplasma hyopneumoniae_ in fattening animals. Onset of immunity: 3 weeks following vaccination. Health Products Regulatory Authority 20 July 2018 CRN000YKD Page 2 of 5 Duration of immunity: 23 weeks following vaccination. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS To the user: This product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this product seek prompt medical advice even if only a very small amount is injected and take the pac Lire le document complet